TLX
Trans-Lux Corp.
NASDAQ · Healthcare · Biotechnology · AU
$12.59
+0.68%Leverage
- Debt / equity
- 1.19x
- Net debt / equity
- 0.67x
- Debt / assets
- 0.43x
- Debt / EBITDA
- 18.11x
- Net debt / EBITDA
- 10.24x
Liquidity & coverage
- Current ratio
- 2.01x
- Quick ratio
- 1.85x
- Cash ratio
- 1.04x
- Interest coverage
- -0.54x
- EBITDA / interest
- 2.47x
- Working capital
- $252.2M
Cash & dividend
- FCF / debt
- -0.10x
- Cash flow / debt
- -0.02x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026